NEFL and Alzheimer disease: However, NfL is not a specific biomarker of AD, but rather a general indicator of ongoing neurodegeneration across several neurodegenerative and neurological disorders (Barro and Zetterberg 2021; Lin et al. 2018; Mattsson et al. 2017).